The EU Postoperative Pain Management Market was valued at USD XX Million in 2019, estimated to grow at a CAGR of 3.96% and reach USD XX Million in 2028

Post-operative pain includes all types of acute pain that occur due to injuries and resolve in an appropriate healing period. Post-operative pain treatment is thus aimed at mobilizing the patient as early as possible. If the patients are not made to undergo a proper post-operative pain treatment, they can potentially develop cardiac problems, chest infections, depression, wound-induced infection, and hypoxia. Post-operative pain treatment has evolved over recent years, with different concepts of how drugs affect the body when used in specific combinations. Among the EU5 countries, Germany had the highest market size, while Spain had the lowest market size of postoperative pain management. The EU market for post-operative pain management drugs is expected to grow due to the presence of a large patient population base suffering pain in the region. The high demand for pain relievers medications in the EU has led to the emergence of numerous drug manufacturing companies



Market Growth Drivers

Despite the many advancements in postoperative pain management, opioids are still considered as the mainstay pain therapy in many settings. All opioids have significant side effects that are limiting their use. An increasing number of surgical procedures is expected to act as a value-driver to the postoperative pain management market. The increase in trauma cases is the major factor for the growth of the market. The rising research and development expenditure in order to introduce highly effective medications are impacting positively on the growth of the postoperative pain management market. According to CDC, the prescription opioid overdose killed around 16,500 people. The increasing cases of drug overdoses and side-effects associated with postoperative pain drugs are expected to act as a restraint to the overall market